← Back to contracts

DoW Peer Reviewed Cancer, Clinical Trial Award

US · MD Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526PRCRPCTA
Response due Oct 05, 2026 · 00:00 UTC

Summary

The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is soliciting applications for a Peer Reviewed Cancer Clinical Trial Award. This is a Department of Defense (DoD) program funding peer-reviewed clinical trials related to cancer research. The opportunity was posted on Grants.gov, indicating this is a federal grant/cooperative agreement mechanism. Specific scope details, award amounts, and eligibility requirements were not included in the synopsis text provided.

How they evaluate

Submission: Grants.gov federal grants portal

Risks & flags

  • Synopsis contains minimal detail — no scope narrative, eligibility criteria, award ceiling, or technical requirements disclosed; full program announcement not yet available for assessment.
  • Short synopsis-only posting makes it difficult to evaluate competitiveness or potential wiring.

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Peer Reviewed Cancer, Clinical Trial A…
Due Oct 05
Onboard